Poster Title

BCLXL and BCLXS as Resistance Markers for BCL2 Inhibitors in Melanoma

Authors

Felipe Dantas, The University of Texas at AustinFollow
Evelyn de Groot, The University of Texas MD Anderson Cancer Center
Cesar Augusto Ruiz Elizondo, The University of Texas MD Anderson Cancer Center
Renato Guerrieri, The University of Texas MD Anderson Cancer Center
Michael A. Davies MD, PhD, The University of Texas MD Anderson Cancer Center
Vashisht YN Gopal, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

Cutaneous melanoma, BCL2, targeted therapy, apoptosis regulation, cell growth

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

ITERT Undergraduate Summer Research Training Program

Recommended Citation

Dantas, Felipe; de Groot, Evelyn; Ruiz Elizondo, Cesar Augusto; Guerrieri, Renato; Davies, Michael A. MD, PhD; and Gopal, Vashisht YN, "BCLXL and BCLXS as Resistance Markers for BCL2 Inhibitors in Melanoma" (2021). Summer Experience 2021. 243.
https://openworks.mdanderson.org/sumexp21/243